Michael Schollmeyer

Title: Michael Schollmeyer: Innovator in Cardiac Implant Technology

Introduction

Michael Schollmeyer is a notable inventor based in Maple Grove, MN (US). He has made significant contributions to the field of cardiac implants, focusing on innovative methods and therapeutic agents that enhance patient care. His work is characterized by a commitment to improving medical technology and patient outcomes.

Latest Patents

Michael Schollmeyer holds a patent for a cardiac implant and methods. This invention includes a conduit or scaffold that features a first therapeutic agent in at least partial covering relation to a first portion of the scaffold, and a second therapeutic agent, different from the first, in at least partial covering relation to a second portion of the scaffold. The therapeutic agents may include antithrombotic agents, anti-inflammatory agents, antiproliferative agents, antibiotic agents, angiogenic agents, antiplatelet agents, anticoagulant agents, rhestenosis preventing agents, hormones, and combinations thereof. The methods for making these cardiac implants involve providing a scaffold, covering portions of it with different therapeutic agents, and forming a blood flow path from a heart chamber directly to a coronary vessel.

Career Highlights

Michael Schollmeyer is currently associated with Percardia, Inc., where he continues to develop innovative solutions in cardiac care. His dedication to research and development has positioned him as a key player in the medical technology industry.

Collaborations

One of his notable coworkers is Katherine S. Tweden. Their collaboration reflects a shared commitment to advancing cardiac health technologies.

Conclusion

Michael Schollmeyer's contributions to cardiac implant technology exemplify the impact of innovation in healthcare. His work not only enhances medical devices but also aims to improve the quality of life for patients.